Skip to main content
. 2021 May 5;36(7):1922–1931. doi: 10.1093/humrep/deab104

Table II.

Patient demographics of matched case-controls for in vitro assessment of PCs.

Cases (n = 17) Controls (n = 17) Significance
Age (years) 28.3 ± 1.3 (21–40) 31.3 ± 1.2 (23–41) NS
BMI (kg/m2) 24.9 ± 1.4 (16.8–38.4) 24.5 ± 1.3 (14.9–38.4) NS
AMH (pmol/L) 27.5 ± 5.2 (4.0–94.2) 26.1 ± 5.7 (6.2–80.3) NS
Day 3 FSH (IU) 5.9 ± 0.6 (0.2–8.4) 7.0 ± 0.4 (0.1–5.6) NS
Peak oestradiol (pmol/L) 13595.8 ± 1912.4 (5460–28 472) 10223.9 ± 974.0 (5864–17 457) NS

NS, not significant. PC, phytocannabinoid.